How Amgen plans to BiTE into CAR-T’s hype
While personalized CAR-T cancer therapies make headlines in biotech, Amgen has been betting big on another tumor-killing approach with, yes, another acronym: BiTEs. The trademarked term [...]
While personalized CAR-T cancer therapies make headlines in biotech, Amgen has been betting big on another tumor-killing approach with, yes, another acronym: BiTEs. The trademarked term [...]
New research shows what can happen with patients in 'off-service' hospital beds. If you end up needing to go to the hospital, often times you're [...]
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers [...]
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A [...]
L’Iperuranio Cinetico di Ferdinando Vassallo a cura di Maria Giovanna Sessa (11 maggio 2018) “Vassallo indaga gli arcani rapporti con gli oggetti, da quelli [...]
Naturalis Historia di Deborah Napolitano a cura di Maria Giovanna Sessa (25 marzo 2017) “La Napolitano, dunque, utilizza il suo alfabeto visivo per esprimere [...]
Universi Eccentrici di Danilo Mariani, a cura di Maria Giovanna Sessa (24 settembre 2016) “Il processo di manipolazione plastica dell’artista tiene congiunti universi concettualmente [...]
THURSDAY, Oct. 6, 2016 (HealthDay News) -- Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast, a new [...]
TUESDAY, Aug. 11, 2015 (HealthDay News) -- Ovarian cancer has a reputation as a swift killer that's often detected at a late stage, but a new study [...]
TUESDAY, Aug. 12 (HealthDay News) — Postmenopausal women with breast cancer who are receiving endocrine treatment may be at increased risk of joint issues, including arthritis, a new study finds. [...]